Compare · CYAN vs PRDS

CYAN vs PRDS

Side-by-side comparison of Cyanotech Corporation (CYAN) and Pardes Biosciences Inc. (PRDS): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CYAN and PRDS operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
  • PRDS has more recent analyst coverage (3 ratings vs 0 for CYAN).
MetricCYANPRDS
Company
Cyanotech Corporation
Pardes Biosciences Inc.
Price
-
-
Market cap
-
-
1M return
-
-
1Y return
-
-
Industry
Medicinal Chemicals and Botanical Products
Medicinal Chemicals and Botanical Products
Exchange
NASDAQ
NASDAQ
IPO
2021
News (4w)
0
0
Recent ratings
0
3
CYAN

Cyanotech Corporation

Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company sells its products as packaged consumer products through distributors, retailers, and online channels, and direct to consumers, as well as in bulk form to manufacturers, formulators, and distributors. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.

PRDS

Pardes Biosciences Inc.

Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome coronavirus 2 infections and associated diseases. The company was incorporated in 2020 and is headquartered in Carlsbad, California.